CollPlant Biotechnologies Q3 2024 Adj EPS $(0.33) Misses $(0.28) Estimate, Sales $4.00K May Not Be Comparable To $416.00K Estimate
CollPlant Biotechnologies Q3 2024 Adj EPS $(0.33) Misses $(0.28) Estimate, Sales $4.00K May Not Be Comparable To $416.00K Estimate
Collplant生物技術2024年第三季度每股收益調整爲$(0.33)，低於$(0.28)的預期，銷售額爲0.4萬美元，可能無法與41.6萬美元的預期數據進行比較。
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.28) by 17.86 percent. This is a 5.71 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $4.00 thousand which missed the analyst consensus estimate of $416.00 thousand by 99.04 percent. This is a 90.70 percent decrease over sales of $43.00 thousand the same period last year.
CollPlant Biotechnologies（納斯達克股票代碼：CLGN）公佈的季度虧損爲每股0.33美元，比分析師普遍預期的0.28美元（0.28美元）低17.86％。這比去年同期每股虧損0.35美元（0.35美元）增長了5.71％。該公司公佈的季度銷售額爲40萬億美元，比分析師普遍預期的41.6萬美元低99.04％。這比去年同期的43,000美元銷售額下降了90.70％。
資訊熱榜
更新時間